Genelux Culture d’entreprise

Dr. Aladar A. Szalay Ph.D. has been the Chairman Emeritus and Chief Scientific Advisor to the Chief Executive Officer at Genelux Corporation since May 2014. Dr. Szalay founded Genelux Corporation in 2001 and served as its Chief Executive Officer until May 2014 and its President until January 10, 2011. He served as Chairman of Genelux Corporation until May 2014. He served as Chief Scientific Officer of Genelux Corporation. He served as the Chairman of Scientific Advisory Board and Member of Scientific Advisory Board of Genelux Corporation. He serves as Member of Advisory Board at Parallel 6, Inc. He was Founding Director of the Center for Molecular Biology and Gene Therapy at Loma Linda University School of Medicine in Loma Linda, California. He was Associate Research Scientist of molecular genetics at Boyce Thompson Institute. He was invited to serve as a genetic engineering, gene transfer and therapy expert for several multi-national pharmaceutical and diagnostic equipment manufacturing companies in the US, Europe and Japan. He served on the Board of Directors and the Scientific Advisory Board for several biomedical start-up companies. He has functioned as an Advisor for numerous research foundations. Dr. Szalay is a University Professor at the Rudolf Virchow Center of Experimental Biomedicine, School of Medicine, and also at the Biocenter at the University of W???rzburg in W???rzburg, Germany, where he directs a research program with graduate students and post-doctoral fellows on whole body imaging. Dr. Szalay was Professor of Molecular Genetics and Microbiology at Loma Linda University School of Medicine, Canadian Pacific Endowed Chair Professor of biotechnology and molecular genetics at the University of Alberta in Edmonton, Canada; and Adjunct Professor at Cornell University in Ithaca, New York. He has published over 160 scientific papers and holds over 50 issued patents and patent applications. Dr. Szalay is the recipient of the Wilhelm Exner Award (Medal for Excellence in Science) from Austria and the Alexander von Humboldt Prize from Germany, among others. Dr. Szalay is internationally recognized as a Leader in the monitoring of gene regulation and in whole cell and live organism imaging using light-emitting proteins or protein fusions. He was Gosney Fellow at the California Institute of Technology in Pasadena, California. He has a Ph.D. in Biochemistry in 1971 and an M.S. in Biochemistry in 1966 from the Institute of Biochemistry, Martin Luther University.